Global CRO Capabilities StageBio operates with facilities in the United States and Germany, offering global scale for histology, pathology, imaging, and archiving services. This presents an opportunity to engage multinational sponsors needing consistent data across regions and streamlined regulatory packages for GLP and SEND.

Regulatory Readiness The company emphasizes audit-ready GLP/SEND-compliant data packages and robust FDA/EMA-ready findings. Sales conversations can focus on reducing study timelines and risk of regulatory setbacks by offering StageBio as a trusted partner for compliant, high-quality datasets.

Pathology Expertise With a team of 20+ board-certified pathologists acting as an extension of the sponsor team, StageBio can position itself as a critical quality and interpretation layer to de-risk studies, particularly for cell and gene therapies and complex histology needs.

End-to-End Services StageBio covers consultancy, necropsy, histology, imaging, digital pathology, and archiving. This breadth enables cross-sell opportunities to existing clients seeking integrated solutions, quicker turnaround, and tighter study oversight from protocol design to data delivery.

Industry Engagement Recent activity at ARVO, SOT, and leadership changes signal active market presence and growth. Leverage industry event participation and leadership visibility to secure introductions with decision-makers exploring advanced morphometry, stereology, and imaging analytics.